Ruifang An

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Xiangyu Gao, Nong Xu, Ziyu Li et al. · The Lancet Oncology · 2023 · 171 citations

Oncology, Medicine, Advanced Solid Tumours +8

Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial

Ning Li, Youzhong Zhang, Jing Wang et al. · Journal of Clinical Oncology · 2022 · 68 citations

Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 bi-specific antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase II trial (075)

Xiaohua Wu, Jiafu Ji, Hanmei Lou et al. · Gynecologic Oncology · 2022 · 60 citations

Cervical Cancer, Phase Ii Trial, Medicine +8

Correlation analysis of sperm DNA fragmentation index with semen parameters and the effect of sperm DFI on outcomes of ART

KangSheng Liu, Xiaodong Mao, Feng Pan et al. · Scientific Reports · 2023 · 60 citations · Full text

Deep Neural Networks Offer Morphologic Classification and Diagnosis of Bacterial Vaginosis

Zhongxiao Wang, Lei Zhang, Min Zhao et al. · Journal of Clinical Microbiology · 2020 · 54 citations · Full text